Literature DB >> 8168940

Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.

F H Azmi1, A H Lucas, H V Raff, D M Granoff.   

Abstract

We determined the heavy (H)- and light (L)-chain variable (V) region nucleotide and translated amino acid sequences of the human immunoglobulin M(kappa) monoclonal antibody (MAb) 5E1, which is specific for the polysaccharide capsule of Escherichia coli K1 and Neisseria meningitidis group B (poly[alpha(2-->8)-N-acetylneuraminic acid]) and which is protective in animal models of infection. The 5E1 VH gene is a member of the VHIIIb family and is 97% homologous to the 9.1 germ line gene. The 5E1 VL gene is a member of the kappa I subgroup and is 98% homologous to the germ line gene, 15A, also known as KLO12. The VL and/or VH genes used by 5E1 are highly homologous to the V genes encoding antibodies to the Haemophilus influenzae type b polysaccharide and to antibodies reactive with self-antigens such as erythrocyte "i," DNA, and thyroid peroxidase. We also produced three murine anti-idiotype (Id) MAbs against 5E1. All three anti-Ids recognize a minor subset of antimeningococcal B polysaccharide antibodies present in serum from normal adults. Two of the anti-Ids define distinct Ids associated with antibodies having kappa I-15A V regions. These 15A-associated Ids are expressed by some heterologous human antimeningococcal B polysaccharide MAbs, and they also are independently expressed by two human MAbs that are specific for either the H. influenzae b polysaccharide or the i erythrocyte antigen and that utilize the kappa I-15A V region. Taken together, these data indicate that the 5E1 antibody uses V regions that recur in the human antibody repertoires to this polysaccharide and to structurally dissimilar polysaccharides and autoantigens. Thus, the poor immunogenicity of poly[alpha(2-->8)-N-acetylneuraminic acid] cannot be explained by the unavailability of certain critical VH and VL genes required for generation of antibody response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168940      PMCID: PMC186406          DOI: 10.1128/iai.62.5.1776-1786.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

Authors:  J Finne; M Leinonen; P H Mäkelä
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

3.  The human VH3b gene subfamily is highly polymorphic.

Authors:  E E Adderson; F H Azmi; P M Wilson; P G Shackelford; W L Carroll
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Junctional diversity is essential to antibody activity.

Authors:  D J Jeske; J Jarvis; C Milstein; J D Capra
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

7.  Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.

Authors:  L Skevakis; C E Frasch; J M Zahradnik; R Dolin
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

8.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Immune response of infants and children to disseminated infections with Neisseria meningitidis.

Authors:  J M Griffiss; B L Brandt; D D Broud; D K Goroff; C J Baker
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

Review 10.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb
View more
  8 in total

Review 1.  Molecular techniques for the investigation of meningococcal disease epidemiology.

Authors:  M C Maiden; M Frosch
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

2.  Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies.

Authors:  Gregory R Moe; Apurva Dave; Dan M Granoff
Journal:  Mol Immunol       Date:  2005-09-02       Impact factor: 4.407

3.  Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region.

Authors:  J S Swartley; J H Ahn; L J Liu; C M Kahler; D S Stephens
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

4.  Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody.

Authors:  Gregory R Moe; Apurva Dave; Dan M Granoff
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody.

Authors:  H Zhang; Z Zhong; L A Pirofski
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

6.  Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease.

Authors:  D M Granoff; S K Kelsey; H A Bijlmer; L Van Alphen; J Dankert; R E Mandrell; F H Azmi; R J Scholten
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

7.  Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain.

Authors:  F H Azmi; A H Lucas; H L Spiegelberg; D M Granoff
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity.

Authors:  Serena Giuntini; Peter T Beernink; Donald C Reason; Dan M Granoff
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.